Ascent Wealth Partners, LLC Gilead Sciences, Inc. Transaction History

Ascent Wealth Partners, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 Aug 21, 2019	SELL	$72.84 - $88.8 $591,533 - $721,144	-8,121 Closed	0 $0
Q4 2017 Aug 21, 2019	BUY	$71.15 - $83.52 $1,423 - $1,670	20 Added 0.25%	8,121 $582,000
Q2 2017 Aug 21, 2019	BUY	N/A	148 Added 1.86%	8,101 $573,000
Q1 2017 Aug 21, 2019	SELL	N/A	-541 Reduced 6.37%	7,953 $540,000
Q4 2016 Aug 21, 2019	BUY	N/A	1,634 Added 23.82%	8,494 $608,000
Q3 2016 Aug 21, 2019	SELL	N/A	-9 Reduced 0.13%	6,860 $543,000
Q2 2016 Aug 21, 2019	SELL	N/A	-105 Reduced 1.51%	6,869 $573,000
Q1 2016 Aug 21, 2019	BUY	N/A	160 Added 2.35%	6,974 $641,000
Q4 2015 Aug 21, 2019	BUY	N/A	115 Added 1.72%	6,814 $690,000
Q3 2015 Aug 21, 2019	BUY	N/A	175 Added 2.68%	6,699 $658,000
Q2 2015 Aug 21, 2019	BUY	N/A	570 Added 9.57%	6,524 $763,000
Q1 2015 Aug 21, 2019	BUY	N/A	5,954 New	5,954 $585,000
Q3 2014 Aug 21, 2019	SELL	N/A	-2,484 Closed	0 $0
Q2 2014 Aug 21, 2019	BUY	N/A	2,484	2,484 $206,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Ascent Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ascent Wealth Partners, LLC with notifications on news.